Navigation Links
Quebec City researchers pave the way for novel treatment of pulmonary hypertension
Date:10/23/2010

Montreal - A Heart and Stroke Foundation researcher has discovered what could be the first truly effective breakthrough in the diagnosis and treatment of pulmonary hypertension, a devastating, life-threatening condition which results in an enlargement of the heart.

"We have discovered an early warning system in a protein called PIM-1," Dr. Sbastien Bonnet told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

Dr. Bonnet has established that the PIM-1 cells can be used as markers of pulmonary hypertension.

"Blood samples were taken from patients to measure PIM-1 expression in the blood," says Dr. Bonnet, who is a professor at Laval University and a researcher at Centre hospitalier universitaire de Qubec. "We were surprised to find that the greater the PIM-1 levels, the more severe the pulmonary hypertension in the patient."

He says this opens the doors to using regular blood tests to look at PIM-1 levels. "If there is a slight increase in PIM-1, we will know that something is going on." This is important since the condition is under-diagnosed and often not discovered until it is in a late stage. Without earlier treatment it has a very poor prognosis. The condition has traditionally been diagnosed by a six minute walking test.

PIM-1 also offers the opportunity to move beyond the diagnosis of pulmonary hypertension to treatment. By blocking the PIM-1 protein, researchers were able to reverse the condition.

"This is a remarkable finding," says Dr. Bonnet. "We have found that using gene therapy to inhibit the inappropriate activation of this protein is a novel and effective therapy that can reverse the disease altogether."

Before this discovery there has been no agent to reverse the disease. Current drug treatments can improve quality of life but to this date there has been nothing that can cure the disease.

"Pulmonary hypertension is a rare but life-threatening condition," says Heart and Stroke Foundation spokesperson Dr. Beth Abramson. "These are often very sick individuals. By the time a patient gets to a doctor, the disease is usually well established." Individuals at increased risk of developing pulmonary hypertension include those with a family history and people with a history of blood clots in the lungs (pulmonary embolism).

She recommends that patients pay particular attention to any symptoms like shortness of breath or extreme tiredness. "There are treatments that can help patients live longer, healthier lives."

Pulmonary hypertension is abnormally high blood pressure in the pulmonary arteries, the arteries which carry blood from the heart to the lungs. The condition makes it more difficult for blood to flow to the lungs, causing shortness of breath, fatigue, and swelling of the feet and ankles. It can make everyday tasks almost impossible.

The number of Canadians with pulmonary hypertension is difficult to estimate, because it is under-diagnosed and the early symptoms are common to other conditions such as asthma and general fatigue. In addition, few studies have been conducted.


'/>"/>

Contact: Jane-Diane Fraser
jfraser@hsf.ca
613-569-4361 x273
Heart and Stroke Foundation of Canada
Source:Eurekalert

Related medicine news :

1. Mount Sinai researchers discover origin of immune cells in the brain
2. UC San Diego researchers identify factor boosting leukemias aggressiveness
3. UCI stem cell researchers to receive $9.35 million in state funding
4. Researchers find better method to help mothers cope with childs cancer and related stress
5. Researchers advocate for more education and attention regarding rare breast cancer
6. Mount Sinai researchers discover why cocaine is so addictive
7. Temperature rhythms keep body clocks in sync, UT Southwestern researchers find
8. Need a study break to refresh? Maybe not, say Stanford researchers
9. Researchers reach consensus on use of deep brain stimulation to treat Parkinsons
10. AACR to honor leading researchers at breast cancer symposium
11. Medical researchers break down costs to care for heart failure patients at the end of life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The founders of ... awarded as winners of American Dreams & Good Housekeeping Seal Initiative, a nationwide ... HSN and Good Housekeeping. , Steven Wang, MD ., a renowned dermatologist ...
(Date:3/23/2017)... , ... March 23, 2017 , ... The Boulevard is ... - 2pm. All events will be located in the Main West Entrance of ... no-cost Child ID event. No appointment is necessary and each child with a parent ...
(Date:3/23/2017)... ... ... “Beyond and Back”: a true-life testimony of tragedy and the miraculous power ... Rose, a wife, mother and grandmother committed to sharing her many spiritual adventures which ... new book presents actual events in the life of her family, which validate her ...
(Date:3/23/2017)... ... 2017 , ... Ogden Clinic, the largest multi-specialty group in ... to expand its focus on patient care by providing an advanced check-in and ... Ogden Clinic, we are working to become a different type of provider, one ...
(Date:3/23/2017)... ... ... Corruption”: a simple and strong explanation of the God’s love. “More Corruption” is the ... asked by God to write a book about Him. , She says, “I’m fed up ... commitment to the Lord God. They have not walked in my shoes and I know ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... Global Colposcope Market by Manufacturers, Countries, Type and Application, ... especially in North America , Europe ... America , Middle East and ... manufacturers, regions, type and application. ... Browse 190 Tables and Figures, 19 Major Company Profiles, ...
(Date:3/23/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, ... English version of the Annual report for 2016 is now ... ... NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine. ... medicines that preserve mitochondrial integrity and function in areas of ...
(Date:3/22/2017)...  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... data solutions, today reported financial and operational results ... December 31, 2016. 2016 Highlights ... 241% compared to the full year 2015  ... entire year  Direct-to-consumer model launched ...
Breaking Medicine Technology: